Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002695 |
---|---|
Receipt number | R000003288 |
Scientific Title | Randomized phase II study of CPT-11 plus TS-1 plus Cetuximab for advanced and/or recurrent colon cancer which are oxaliplatin-resistant and KRAS wild type (OGSG 0901) |
Date of disclosure of the study information | 2009/10/31 |
Last modified on | 2021/11/15 23:10:58 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/10/31 16:17:36 | ||
2 | Update | 2011/02/09 17:45:51 | Target sample size |
|
3 | Update | 2011/02/09 17:48:33 | Last follow-up date |
|
4 | Update | 2011/06/03 17:59:00 | Last follow-up date |
|
5 | Update | 2021/11/15 23:10:58 | Public title Public title Scientific Title Scientific Title |